Trials / Completed
CompletedNCT04065711
Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite
Multi-Center Study of the Soliton Rapid Acoustic Pulse (RAP) Device for the Treatment of Cellulite
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 67 (actual)
- Sponsor
- Soliton · Industry
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the safety, and efficacy of Soliton's Rapid Acoustic Pulse (RAP) device for the temporary improvement in the appearance of cellulite.
Detailed description
Multi-site clinical study to evaluate the safety, efficacy and tolerability of Soliton's Rapid Acoustic Pulse (RAP) device fo the temporary improvement in the appearance of cellulite.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Soliton's Rapid Acoustic Pulse (RAP) | Treatment for the temporary improvement in the appearance of cellulite. |
Timeline
- Start date
- 2019-07-20
- Primary completion
- 2021-07-20
- Completion
- 2021-08-26
- First posted
- 2019-08-22
- Last updated
- 2021-09-22
Locations
4 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04065711. Inclusion in this directory is not an endorsement.